Not applicableUnknownNCT04021212What this trial is testingPituitary Adenoma and Serum LipidWho this might be right forPituitary Adenoma 1, Acth-Secreting Shandong Provincial Hospital 1,000
Not applicableStudy completedNCT02803697What this trial is testingPredictive Factors of Recurrence of Non Functioning Pituitary Adenomas : a Retrospective Study of 220 Patients in the Reims University Hospital, FranceWho this might be right forPituitary Adenomas CHU de Reims 106
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)WithdrawnNCT00003514What this trial is testingAntineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation TherapyWho this might be right forMerkel Cell CarcinomaIslet Cell CarcinomaNeuroendocrine Carcinoma+1 more Burzynski Research Institute
Early research (Phase 1)Ended earlyNCT00002947What this trial is testingIndium In 111 Pentetreotide in Treating Patients With Refractory CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more Yale University 35
Testing effectiveness (Phase 2)Study completedNCT00939523What this trial is testingTargeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard TherapyWho this might be right forPituitary AdenomasProlactinomas Cedars-Sinai Medical Center 9
Not applicableEnded earlyNCT00796783What this trial is testingConfirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of HypercortisolemiaWho this might be right forCushing's Syndrome Corcept Therapeutics 2
Testing effectiveness (Phase 2)WithdrawnNCT00601289What this trial is testingTemozolomide in Treating Patients With Invasive Pituitary TumorsWho this might be right forBrain and Central Nervous System Tumors Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03930771What this trial is testingCapecitabine and Temozolomide for Treatment of Recurrent Pituitary AdenomasWho this might be right forRecurrent Pituitary Adenomas Weill Medical College of Cornell University 1
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Not applicableStudy completedNCT06826170What this trial is testingHypofractionated Radiosurgery to Treat Residual/Recurrent Non Secreting Pituitary Adenoma (HYPOADENO)Who this might be right forPituitary NeoplasmsPituitary Adenoma Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 25
Not applicableStudy completedNCT00255671What this trial is testingAcute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain DisordersWho this might be right forBrain and Central Nervous System TumorsMetastatic CancerRadiation Toxicity Case Comprehensive Cancer Center 76
Not applicableUnknownNCT03457389What this trial is testingComparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With ProlactinomaWho this might be right forPituitary AdenomaProlactinomaPituitary Tumor+1 more Seoul National University Hospital 68
Early research (Phase 1)Ended earlyNCT01088763What this trial is testingGamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaWho this might be right forChildhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more National Cancer Institute (NCI) 129